Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Structure Therapeutics Inc. - American Depositary Shares (NQ: GPCR ) 40.27 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Structure Therapeutics Inc. - American Depositary Shares < Previous 1 2 3 Next > 7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 May 09, 2024 The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving. Via InvestorPlace 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly. Via InvestorPlace 7 Small-Cap Stocks that Wall Street Loves for Good Reason March 30, 2024 As small-cap stocks start to catch up to the market rally, it's time to look at seven small-cap stocks that Wall Street loves. Via InvestorPlace GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023 March 15, 2024 GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace The Best-Performing U.S. IPOs Of 2023 February 04, 2024 In 2023, there were 154 IPOs on the U.S. stock market. Here is a look at some of the best initial public offerings from last year. Via Talk Markets 2 Biotech Stocks That Could Soar in December November 26, 2023 These two biotechs have important catalysts coming up in December. Via The Motley Fool What 6 Analyst Ratings Have To Say About Structure Therapeutics November 15, 2023 Via Benzinga 4 Analysts Have This to Say About Structure Therapeutics October 19, 2023 Via Benzinga Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. Via Investor's Business Daily Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now December 25, 2023 It has genuine struggles ahead, but it has some actual value in hand as well. Via The Motley Fool 7 Small-Cap Stocks That Wall Street Loves for Good Reason December 22, 2023 The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading Via InvestorPlace Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review December 22, 2023 Despite a Wednesday tumble, the major indexes are right at 2023 highs. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 19, 2023 Via Benzinga Nasdaq Gains 100 Points; Biomerica Shares Spike Higher December 18, 2023 U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07.... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session December 18, 2023 Via Benzinga Crude Oil Rises 3%; US Housing Market Index Increases In December December 18, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session December 18, 2023 Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... Via Benzinga Why Is Novo Nordisk's Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today? December 18, 2023 Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development program update for its highly selective oral GLP-1 Via Benzinga Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel December 18, 2023 U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.15% to 37,362.28 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Structure Stock Takes A Brutal Beating After Obesity Drug Trails Lilly's Leader December 18, 2023 The company is hoping to break into the pack with an oral GLP-1 agonist. Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's Pre-Market Session December 18, 2023 Via Benzinga 3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 December 11, 2023 Some of the most explosive opportunities can be found in biotech stocks. In fact, as we head into New Year 2024, here are three to consider. Via InvestorPlace If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names November 29, 2023 As we head into December 2023, some of the hottest investment opportunities can be found in these biotech stocks. Via InvestorPlace Should You Still Buy the Nasdaq's Best-Performing October Stocks? November 03, 2023 Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them. Via The Motley Fool Top 5 Health Care Stocks That Should Keep You Up At Night October 26, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023 October 19, 2023 Via Benzinga BMO Capital Maintains Outperform Rating for Structure Therapeutics: Here's What You Need To Know October 03, 2023 Via Benzinga Why Shares of Structure Therapeutics Are Up Monday October 02, 2023 The stock climbed for the second straight day after the company reported positive trial data for its weight-loss therapy drug. Via The Motley Fool Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 29, 2023 Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 29, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.